| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 23.553 | 36.151 | 56.450 | 61.706 | 62.421 | 64.997 | 62.369 | 63.899 | 75.433 |
| Total Income - EUR | - | 23.553 | 36.151 | 56.450 | 61.707 | 62.423 | 64.999 | 62.371 | 63.899 | 75.435 |
| Total Expenses - EUR | - | 12.321 | 19.530 | 24.229 | 26.070 | 28.745 | 24.764 | 27.147 | 22.794 | 27.553 |
| Gross Profit/Loss - EUR | - | 11.232 | 16.621 | 32.222 | 35.637 | 33.678 | 40.235 | 35.224 | 41.105 | 47.882 |
| Net Profit/Loss - EUR | - | 10.996 | 16.259 | 31.657 | 35.020 | 33.095 | 39.585 | 34.601 | 40.466 | 45.619 |
| Employees | - | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Ciocîrdel Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 482 | 331 | 177 | 25 |
| Current Assets | - | 12.141 | 27.636 | 51.835 | 78.892 | 68.030 | 102.479 | 85.990 | 43.368 | 48.154 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.326 | 3.161 | 6.316 | 7.280 | 6.795 | 10.494 | 5.790 | 31.916 | 35.410 |
| Cash | - | 9.815 | 24.475 | 45.518 | 71.612 | 61.235 | 91.985 | 80.199 | 11.452 | 12.744 |
| Shareholders Funds | - | 11.041 | 16.312 | 31.709 | 35.070 | 33.145 | 39.633 | 34.649 | 40.515 | 45.667 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.100 | 11.324 | 20.126 | 43.822 | 34.885 | 63.327 | 51.671 | 3.031 | 2.512 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ciocîrdel Med Srl